Scientific News Biology To unknown science animals and plants NEW WAY FOUND TO SEE LIGHT THROUGH NOVEL PROTEIN IDENTIFIED BY DARTMOUTH GENETICISTS
NEW WAY FOUND TO
SEE LIGHT THROUGH NOVEL PROTEIN IDENTIFIED BY DARTMOUTH GENETICISTS
Dartmouth
Medical School geneticists have
discovered a new class of proteins that see light, revealing a previously
unknown system for how light works.
The novel photoreceptors are part of the gears
that drive biological clocks, the cellular timekeepers of the circadian rhythm,
which paces life's daily ebb and flow in a 24-hour light-dark cycle. Their
identification also opens a window for genetically engineered drug delivery
systems that exploit the properties of these newfound molecules.
The findings, by Drs. Jay Dunlap and Jennifer
Loros, and graduate student Allan Froehlich, will be published in an upcoming
issue of Science; they are currently reported online in Science Express.
Dunlap, professor and chair of genetics, and
Loros, professor of biochemistry, were the first to delineate circadian
clockwork in Neurospora, the common bread mold and one of the best-known genetic
model systems. They pieced together how the circadian cycle works and
demonstrated how light resets it through a complex of interwoven molecular
messages.
"That left open the question then of what
actually absorbed the light. What we found is a new paradigm within clocks,"
Dunlap says. "Light is absorbed by a molecule that is actually within the
clock and is an activating element in the clock cycle. This is a new molecular
mechanism to see light and a new way for light to have an effect. Although the
protein has been known for sometime, this is a configuration of activities
that's not been reported before for any protein."
Since bread mold belongs to the fungal
phylogenetic kingdom, eventually researchers may be able to harness the proteins
against fungal disease. "Virtually nothing is known about how pathogenic
fungi respond to light or whether that can be exploited for a noninvasive
therapy," Dunlap acknowledges. It may be a long shot, but drug therapies
start with properties people don't have. "If you want to do therapy--antifungal,
antibacterial or anything--you start looking for biochemical activities that the
host does not have that can be targeted on the pathogen."
Froelich, a graduate student with Dunlap and
Loros, built on their discovery that the gene frequency (frq) encodes a central
cog of the clock cycle and that light resets the clock by acting on frq. He
identified the frq parts necessary and sufficient for light induced expression
of the gene, and determined that the proteins that bind to these parts are the
clock proteins White Collar-1 and White Collar-2 (WC-1 and WC-2). He then showed
that both proteins were sufficient for binding, that under appropriate
biochemical conditions they could also detect light and, subsequently, that WC-1
is actually the photoreceptor protein.
WC-1 is a transcription factor that partners with
WC-2, and binds to DNA of light-regulated genes. Transcription factors are
proteins whose role is to regulate expression of genes; they bind to DNA and
turn on genes, Dunlap explains. "This is the first case of a transcription
factor that is itself a photo pigment and a transcription factor that contains
both ability to turn on gene expression and ability to do that in response to
light within the same protein."
###
For further information, contact Jay Dunlap at: http://Jay.Dunlap@dartmouth.edu/.
Contact: DMS Communications, dms.communications@dartmouth.edu,
603-650-1492, Dartmouth Medical School
Source of the given news and the copyrights
belong to a Dartmouth
Medical School
Publishing date: July 16, 2002
Back
|